BIND Therapeutics Inc (BINDQ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Andrew J. Hirsch
Employees:
393
325 VASSAR STREET, CAMBRIDGE, MA 02139
6174913400

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

BIND Therapeutics, Inc., a biotechnology company, develops novel targeted therapeutics primarily for the treatment of cancer in the United States and Russia.

Data derived from most recent annual or quarterly report
Market Cap 16.333 Million Shares Outstanding20.887 Million Avg 30-day Volume 2.176 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million

Are you looking for this stock instead?

View SEC Filings from BINDQ instead.

View recent insider trading info

Funds Holding BINDQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BINDQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUTT PETER BARTON

  • Director
15,000 2016-08-29 0

ROWINSKY ERIC K

  • Director
15,000 2016-08-29 0

LYNCH DANIEL

  • Director
  • CHAIRMAN
20,000 2016-08-26 0

LANGER ROBERT

  • Director
738,424 2016-08-26 0

ROWLAND CHARLES A JR

  • Director
15,000 2016-08-26 0

TZIANABOS ARTHUR

  • Director
15,000 2016-08-26 0

BERMAN GEOFFREY L CHIEF RESTRUCTURING OFFICER

  • Officer
0 2016-08-01 0

YINGLING JONATHAN MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-12-14 0

TROIANO GREGORY SENIOR VICE PRESIDENT

  • Officer
5,343 2015-10-26 0

HIRSCH ANDREW PRESIDENT & CEO

  • Officer
  • Director
0 2015-06-22 0

SCHULMAN AMY W

  • Director
0 2015-06-09 0

NASHAT AMIR

  • Director
0 2015-06-09 0

LINDBLOM CHRISTOPHER M SVP, FINANCE & ADMINISTRATION

  • Officer
0 2015-03-07 0

YOUSSOUFIAN HAGOP CHIEF MEDICAL OFFICER

  • Officer
0 2015-03-07 0

KOERWER DAN CHIEF BUSINESS OFFICER

  • Officer
0 2015-03-07 0

MINICK SCOTT PRESIDENT & CEO

  • Officer
  • Director
441,135 2014-12-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments